Literature DB >> 972193

Caprylate-thallous agar medium for selectively isolating Serratia and its utility in the clinical laboratory.

M P Starr, P A Grimont, F Grimont, P B Starr.   

Abstract

A defined agar medium (hereinafter designated caprylate-thallous [CT5 agar) containing 0.01% yeast extract, 0.1% caprylic (n-octanoic) acid, and 0.025% thallous sulfate is highly selective for all Serratia species and effectively discriminates against most non-Serratia strains likely to be in the same habitats. The selectivity of CT agar is demonstrated by the very high efficiency of colony formation (mean, 80.7% of that on a nonselective complex medium) on CT agar by known Serratia strains and the very low efficiency of colony formation (close to zero) on CT agar by bacterial strains known not to be Serratia. The utility of this medium in actual clinical laboratory practice is demonstrated by the more rapid and higher recovery of Serratia on this selective medium as compared to conventional procedures of in-tandem runs of 513 consecutive urine, feces, and sputum specimens. Pigmented and nonpigmented Serratia strains deliberately added to fecal specimens can be selectively and quantitatively recovered on CT agar. CT agar compares favorably with, or in some cases is an improvement over, other selective media which have been recommended for isolating Serratia. This selective CT agar medium could be quite useful in ecological surveys, especially those related to hospital-acquired infections.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 972193      PMCID: PMC274449          DOI: 10.1128/jcm.4.3.270-276.1976

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Role of Serratia species in urinary tract infections.

Authors:  L J LANCASTER
Journal:  Arch Intern Med       Date:  1962-05

2.  Infection due to chromobacteria; report of 11 cases.

Authors:  R P WHEAT; A ZUCKERMAN; L A RANTZ
Journal:  AMA Arch Intern Med       Date:  1951-10

3.  A direct culture method for the examination of milk samples.

Authors:  C D WILSON; G SLAVIN
Journal:  J Comp Pathol       Date:  1950-07       Impact factor: 1.311

4.  Isolation of Serratia marcescens on deoxyribonuclease-toluidine blue-cephalothin agar.

Authors:  J J Farmer; F Silva; D R Williams
Journal:  Appl Microbiol       Date:  1973-01

5.  Serratia marcescens. Biochemical characteristics, antibiotic susceptibility patterns, and clinical significance.

Authors:  C J Wilkowske; J A Washington; W J Martin; R E Ritts
Journal:  JAMA       Date:  1970-12-21       Impact factor: 56.272

6.  An outbreak of Serratia marcescens, and its control.

Authors:  H A Cabrera
Journal:  Arch Intern Med       Date:  1969-06

7.  Serratia marcescens septicemia. A new threat in surgery.

Authors:  W A Altemeier; W R Culbertson; W D Fullen; J J McDonough
Journal:  Arch Surg       Date:  1969-08

8.  Infection by Serratia marcescens in premature children.

Authors:  F Ragazzini; C La Cauza; M Ferrucci
Journal:  Ann Paediatr       Date:  1965

9.  Erythritol as a selective substrate for the growth of Serratia marcescens.

Authors:  I J Slotnick; M Dougherty
Journal:  Appl Microbiol       Date:  1972-08

10.  Serratia marcescens: biochemical, serological, and epidemiological characteristics and antibiotic susceptibility of strains isolated at Boston City Hospital.

Authors:  J N Wilfert; F F Barrett; W H Ewing; M Finland; E H Kass
Journal:  Appl Microbiol       Date:  1970-02
View more
  16 in total

1.  The anticancer agent prodigiosin is not a multidrug resistance protein substrate.

Authors:  Fatemeh Elahian; Bahareh Moghimi; Farideh Dinmohammadi; Mahsa Ghamghami; Mehrdad Hamidi; Seyed Abbas Mirzaei
Journal:  DNA Cell Biol       Date:  2013-02-01       Impact factor: 3.311

2.  Occurrence of sep insecticidal toxin complex genes in Serratia spp. and Yersinia frederiksenii.

Authors:  Steven J Dodd; Mark R H Hurst; Travis R Glare; Maureen O'Callaghan; Clive W Ronson
Journal:  Appl Environ Microbiol       Date:  2006-10       Impact factor: 4.792

3.  Absence of Serratia marcescens in faecal samples from normal individuals.

Authors:  P A Parment
Journal:  Infection       Date:  1983 May-Jun       Impact factor: 3.553

4.  Precipitate produced by Serratia marcescens on MacConkey agar: useful diagnostic test.

Authors:  W A Black
Journal:  J Clin Microbiol       Date:  1978-11       Impact factor: 5.948

5.  Use of colistin and sorbitol for better isolation of Serratia marcescens in clinical samples.

Authors:  G M Grasso; M M D'Errico; F Schioppa; F Romano; D Montanaro
Journal:  Epidemiol Infect       Date:  1988-10       Impact factor: 2.451

6.  Biotyping of Serratia marcescens and its use in epidemiological studies.

Authors:  P A Grimont; F Grimont
Journal:  J Clin Microbiol       Date:  1978-07       Impact factor: 5.948

7.  L-Arabinose-ornithine-Irgasan medium for differentiating Serratia species.

Authors:  S Gibson; H Friedman
Journal:  J Clin Microbiol       Date:  1978-03       Impact factor: 5.948

8.  Identification of a Serratia entomophila genetic locus encoding amber disease in New Zealand grass grub (Costelytra zealandica).

Authors:  N M Upadhyaya; T R Glare; H K Mahanty
Journal:  J Bacteriol       Date:  1992-02       Impact factor: 3.490

Review 9.  Case report and review of septicemia due to Serratia ficaria.

Authors:  H Darbas; H Jean-Pierre; J Paillisson
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

10.  Serratia ficaria: a misidentified or unidentified rare cause of human infections in fig tree culture zones.

Authors:  T Anahory; H Darbas; O Ongaro; H Jean-Pierre; P Mion
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.